Top Suppliers:I want be here

190274-53-4

190274-53-4 structure
190274-53-4 structure
  • Name: Calpain Inhibitor VI
  • Chemical Name: 2-[(4-fluorophenyl)sulfonylamino]-3-methyl-N-(4-methyl-1-oxopentan-2-yl)butanamide
  • CAS Number: 190274-53-4
  • Molecular Formula: C17H25FN2O4S
  • Molecular Weight: 372.455
  • Catalog: Signaling Pathways Metabolic Enzyme/Protease Proteasome
  • Create Date: 2018-12-26 12:20:49
  • Modify Date: 2024-01-06 20:23:39
  • Calpain Inhibitor VI (SJA6017) is a synthesized peptide aldehyde inhibitor of calpain. Calpain Inhibitor VI inhibits purified m-calpain with the IC50 of 80 nM. Calpain Inhibitor VI can be used for the research of cataract[1].

Name 2-[(4-fluorophenyl)sulfonylamino]-3-methyl-N-(4-methyl-1-oxopentan-2-yl)butanamide
Synonyms N-[(4-Fluorophenyl)sulfonyl]-N-[(2S)-4-methyl-1-oxo-2-pentanyl]-L-valinamide
N-((4-Fluorophenyl)sulfonyl)-L-valyl-L-leucinal
IN1503
Butanamide, 2-[[(4-fluorophenyl)sulfonyl]amino]-N-[(1S)-1-formyl-3-methylbutyl]-3-methyl-, (2S)-
(2R)-2-[(4-fluorophenyl)sulfonylamino]-3-methyl-N-[(2S)-4-methyl-1-oxopentan-2-yl]butanamide
calpain inhibitor VI
4-fluorophenylsulfonyl-Val-Leu-CHO
(1'S,2S)-2-(4-fluorobenzenesulfonylamino)-N-(1-formyl-3-methylbutyl)-3-methylbutyramide
Description Calpain Inhibitor VI (SJA6017) is a synthesized peptide aldehyde inhibitor of calpain. Calpain Inhibitor VI inhibits purified m-calpain with the IC50 of 80 nM. Calpain Inhibitor VI can be used for the research of cataract[1].
Related Catalog
References

[1]. C Fukiage, et al. SJA6017, a newly synthesized peptide aldehyde inhibitor of calpain: amelioration of cataract in cultured rat lenses. Biochim Biophys Acta. 1997 Oct 24;1361(3):304-12.

Density 1.2±0.1 g/cm3
Molecular Formula C17H25FN2O4S
Molecular Weight 372.455
Exact Mass 372.151917
PSA 100.72000
LogP 3.21
Index of Refraction 1.512

~60%

190274-53-4 structure

190274-53-4

Literature: Senju Pharmaceutical Co., Ltd. Patent: EP1557407 A1, 2005 ; Location in patent: Page/Page column 6 ;

~74%

190274-53-4 structure

190274-53-4

Literature: Payne, Richard J.; Brown, Karina M.; Coxon, James M.; Morton, James D.; Lee, Hannah Yun-Young; Abell, Andrew D. Australian Journal of Chemistry, 2004 , vol. 57, # 9 p. 877 - 884

~%

190274-53-4 structure

190274-53-4

Literature: Inoue, Jun; Nakamura, Masayuki; Cui, Ying-She; Sakai, Yusuke; Sakai, Osamu; Hill, Jeanette R.; Wang, Kevin K. W.; Yuen, Po-Wai Journal of Medicinal Chemistry, 2003 , vol. 46, # 5 p. 868 - 871

~%

190274-53-4 structure

190274-53-4

Literature: Inoue, Jun; Nakamura, Masayuki; Cui, Ying-She; Sakai, Yusuke; Sakai, Osamu; Hill, Jeanette R.; Wang, Kevin K. W.; Yuen, Po-Wai Journal of Medicinal Chemistry, 2003 , vol. 46, # 5 p. 868 - 871

~%

190274-53-4 structure

190274-53-4

Literature: Inoue, Jun; Nakamura, Masayuki; Cui, Ying-She; Sakai, Yusuke; Sakai, Osamu; Hill, Jeanette R.; Wang, Kevin K. W.; Yuen, Po-Wai Journal of Medicinal Chemistry, 2003 , vol. 46, # 5 p. 868 - 871

~%

190274-53-4 structure

190274-53-4

Literature: Inoue, Jun; Nakamura, Masayuki; Cui, Ying-She; Sakai, Yusuke; Sakai, Osamu; Hill, Jeanette R.; Wang, Kevin K. W.; Yuen, Po-Wai Journal of Medicinal Chemistry, 2003 , vol. 46, # 5 p. 868 - 871

~%

190274-53-4 structure

190274-53-4

Literature: Payne, Richard J.; Brown, Karina M.; Coxon, James M.; Morton, James D.; Lee, Hannah Yun-Young; Abell, Andrew D. Australian Journal of Chemistry, 2004 , vol. 57, # 9 p. 877 - 884

~%

190274-53-4 structure

190274-53-4

Literature: Payne, Richard J.; Brown, Karina M.; Coxon, James M.; Morton, James D.; Lee, Hannah Yun-Young; Abell, Andrew D. Australian Journal of Chemistry, 2004 , vol. 57, # 9 p. 877 - 884